Hostname: page-component-78c5997874-mlc7c Total loading time: 0 Render date: 2024-11-19T11:21:22.728Z Has data issue: false hasContentIssue false

The antibacterial activity of acetic acid and Burow's solution as topical otological preparations

Published online by Cambridge University Press:  29 June 2007

M. A. Thorp*
Affiliation:
Departments of Otolaryngology, University of Cape Town, South Africa.
J. Kruger
Affiliation:
Departments of Microbiology, University of Cape Town, South Africa.
S. Oliver
Affiliation:
Departments of Microbiology, University of Cape Town, South Africa.
E. L. K. Nilssen
Affiliation:
Departments of Otolaryngology, University of Cape Town, South Africa.
C. A. J. Prescott
Affiliation:
Departments of Otolaryngology, University of Cape Town, South Africa.
*
Address for correspondence: Dr M. A. Thorp, Department of Otolaryngology, Groote Schuur Hospital, Observatory 7925, Republic of South Africa.

Abstract

At present there are no topical otological preparations on the World Health Organisation's essential drug list, largely due to the ototoxic potential of preparations containing aminoglycoside antibiotics. Acetic acid and Burow's solution have long been used in the treatment of the discharging ear. The aim of this study was to ascertain the antibacterial activity of these two preparations against the most commonly occurring bacteria isolated from discharging ears in our department. Twenty fresh isolates of each of the following organisms – Pseudomonas aeruginosa, Staphylococcus aureus, Proteus mirabilis and Streptococcus pyogenes – were plated onto blood agar and tested against one per cent, two per cent and three per cent acetic acid and Burow's solution (13 per cent aluminium acetate). The activity of each agent was ascertained by the size of the zone of inhibition of bacterial growth. Burow's solution showed significantly larger average zones of inhibition than acetic acid (p < 0.001). The two per cent and three per cent acetic acid as well as the Burow's solution were active against all the organisms tested.

Type
Main Articles
Copyright
Copyright © JLO (1984) Limited 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Cookson, B. D. (1998) The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. Journal of Antimicrobial Chemotherapy 41: 1118.CrossRefGoogle ScholarPubMed
Dibb, W. L. (1985) In vitro efficacy of otic domeboro against Pseudomonas aeruginosa. Undersea Biomedical Research 12(3): 307313.Google ScholarPubMed
Dollery, S. (1991). Therapeutic Drugs. Churchill Livingstone, London, pp A62A63.Google Scholar
Dorland's Illustrated Medical Dictionary. (1994) W. B. Saunders Company, Philadelphia, p 238.Google Scholar
Jones, E. H. (1965) Otitis Externa – Diagnosis and Treatment. Charles C. Thomas, Springfield, Illinois.Google Scholar
Leyden, J. J., Kligman, A. M. (1975) Aluminium chloride in the treatment of symptomatic athlete's foot. Archives of Dermatology 111: 10041010.CrossRefGoogle Scholar
Martindale, W. (1990) The Extra Pharmacopoeia. Pharmaceutical Press, London, p 777.Google Scholar
Nilssen, E. L. K., Wormald, P. J., Oliver, S. (1996) Glycerol and ichthammol: medicinal solution or mythical potion? Journal of Otology and Laryngology 110: 319321.CrossRefGoogle ScholarPubMed
Smith, A. W., Hatcher, J., Mackensie, I. J., Thompson, S., Bal, I., Macharia, I., Mugwe, P., Okoth-Olende, C., Oburra, H., Wanjohi, Z. (1996). Randomised controlled trail of treatment of chronic suppurative otitis media in Kenyan schoolchildren. Lancet 348: 11281133.CrossRefGoogle Scholar